English | Français  

Home

Project Results

What is a Quality Measure?

Who is CEQM?

National Consensus

National Consensus Summary

Top 30 Quality Measures

Quality Measures Database

Priority Domains

Data Infrastructure

Measurement Implementation

Knowledge Transfer / Communication

Project Activities

Contact

Links



Staff/Partner log-in
  

Quality Measures Database

Detailed Results


Use checkboxes to select measures to print or display              
Cognitive Behavioural Therapy for Psychosis Overall Rank: 117
All individuals with schizophrenia who are experiencing persisting psychotic symptoms should be offered cognitive behavioural therapy (CBT) for psychosis.
Psychosis refers to a serious mental disorder (such as schizophrenia) characterized by defective or lost contact with reality, often with hallucinations or delusions.
Additional Domain(s) : Psychotherapy, Accessibility
Rationale
Psychological treatments should be an indispensable part of the treatment options available for service users and their families in the effort to promote recovery. Those with the best evidence of effectiveness are cognitive behavioural therapy and family interventions. These should be used to prevent relapse, to reduce symptoms, increase insight and promote adherence to medication.
Primary Reference
National Collaborating Centre for Mental Health. (2002). Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. London, UK: National Institute for Clinical Excellence. Retrieved on Aug 3, 2006 from: http://www.nice.org.uk/page.aspx?o=CG001NICEguideline
Level of Evidence
II: Less rigorous studies specifically focused on primary mental health care or extrapolated from higher quality studies from secondary mental health care.

Summarized CommentsAdd Comment
  • * This intervention should be offered on a case by case basis, e.g. those too depressed to focus and those with intellectual impairment may not benefit from it.
  • * CBT for psychosis is not freely available in my area.
  • This is not actionable in PHC
Variation in Results
Ratings-based Rank
Relevance 125
Actionability 132
Overall Importance 92
 
Stakeholder Rank
Academics 110
Clinicians 136
Consumers 117
Decision Makers 108
 
Special Group Rank
First Nations 119
Rural Areas 120
Federal Stakeholders 66
Regional Rank
BC AB SK MB ON QC NB NS PE NL YT NT NU
128 108 140 135 140 92 140 126 122 118 47 128 105
 
Overall Rank

      

117


SA11b (H476)

 
Distribution of Survey Respondent Ratings
Relevance
100
90
80
70
60
50
40
30
20
10
0
1.64 1.53 3.37 2.62 8.85 15.66 31.51 21.03 13.79
1 2 3 4 5 6 7 8 9
Low High
Actionability
100
90
80
70
60
50
40
30
20
10
0
2.18 2.87 4.53 3.6 14.52 14.87 29.96 14.81 12.64
1 2 3 4 5 6 7 8 9
Low High
Overall Importance
100
90
80
70
60
50
40
30
20
10
0
7.54 46.99 45.48
3 2 1

3 = can live without
2 = nice to have
1 = indispensable
Use checkboxes to select measures to print or display              

Copyright © 2006 CEQM and CARMHA • infoceqm-acmq.com

The views expressed herein do not necessarily represent the official policies of Health Canada